WO2026126119 - COMPOSITION FOR INTIMATE USE SERUM
National phase entry is expected:
Publication Number
WO/2026/126119
Publication Date
18.06.2026
International Application No.
PCT/IB2025/062677
International Filing Date
10.12.2025
Title **
[English]
COMPOSITION FOR INTIMATE USE SERUM
[French]
COMPOSITION POUR SÉRUM À USAGE INTIME
Applicants **
STROMMER, INC.
Inventors
STROMMER, Kelly
Priority Data
2418092.9
10.12.2024
GB
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1880 | |
| EPO | Filing, Examination, Granting | 8126 | |
| Japan | Filing, Examination, Granting | 1970 | |
| South Korea | Filing, Examination, Granting | 1694 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
18,410
Contact Us
Abstract[English]
A method of restoring and/or maintaining a healthy genital ecosystem comprising administering a genital care composition including: - a postbiotic, - plant-based glycogen, and - plant-based stem cells.[French]
Procédé de restauration et/ou de maintien d'un écosystème génital sain comprenant l'administration d'une composition de soin génital comprenant : - un postbiotique, - du glycogène d'origine végétale, et - des cellules souches d'origine végétale.